Karonova, 80 patient vitamin D sufficiency study: 79% lower mortality [p=0.11] and 71% lower severe cases [p=0.07] https://c19p.org/karonova
copied to clipboard
Serum 25(oH)D level in patients with CoVID-19
et al., Infectology, doi:10.22625/2072-6732-2020-12-3-21-27
Retrospective 80 COVID-19 patients showing low vitamin D levels associated with severity and mortality.
|
risk of death, 79.4% lower, RR 0.21, p = 0.11, high D levels 1 of 23 (4.3%), low D levels 12 of 57 (21.1%), NNT 6.0, odds ratio converted to relative risk, >20ng/ml.
|
|
risk of severe case, 71.1% lower, RR 0.29, p = 0.07, high D levels 3 of 23 (13.0%), low D levels 22 of 57 (38.6%), NNT 3.9, odds ratio converted to relative risk, >20ng/ml.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Karonova et al., 12/31/2020, retrospective, Russia, Europe, peer-reviewed, 3 authors.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.